5-(2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yloxy)pyridin-2-amine → HCID 86270404, compound
Reaction equation
[CH3:1][N:2]1[CH:6]=[C:5]([C:7]2[CH:12]=[C:11]([O:13][C:14]3[CH:15]=[CH:16][C:17]([NH2:20])=[N:18][CH:19]=3)[CH:10]=[CH:9][N:8]=2)[CH:4]=[N:3]1.[CH3:21][C:22]1([CH3:37])[CH2:27][CH:26]([N:28]2[CH2:32][CH2:31][N:30]([C:33](Cl)=[O:34])[C:29]2=[O:36])[CH2:25][CH2:24][O:23]1>C(Cl)Cl>[CH3:21][C:22]1([CH3:37])[CH2:27][CH:26]([N:28]2[CH2:32][CH2:31][N:30]([C:33]([NH:20][C:17]3[CH:16]=[CH:15][C:14]([O:13][C:11]4[CH:10]=[CH:9][N:8]=[C:7]([C:5]5[CH:4]=[N:3][N:2]([CH3:1])[CH:6]=5)[CH:12]=4)=[CH:19][N:18]=3)=[O:34])[C:29]2=[O:36])[CH2:25][CH2:24][O:23]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A 0° C. solution of Example A2 (0.060 g, 0.224 mmol) and TEA (0.094 mL, 0.673 mmol) in DCM (1 mL) was treated with a solution of crude 3-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-oxoimidazolidine-1-carbonyl chloride (0.088 g, 0.337 mmol) in DCM (1 mL). The mixture was warmed to RT, stirred for 0.5 h, then concentrated to dryness and purified via silica gel chromatography (MeOH/DCM) to afford 3-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-(5-((2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)oxy)pyridin-2-yl)-2-oxoimidazolidine-1-carboxamide as an off-white solid (74 mg, 67%). 1H NMR (400 MHz, DMSO-d6): δ 10.96 (s, 1 H), 8.36 (d, J=5.7 Hz, 1 H), 8.25 (s, 1 H), 8.21 (m, 1 H), 8.05 (m, 1 H), 7.96 (d, J=0.7 Hz, 1 H), 7.72 (dd, J=9.0, 2.9 Hz, 1 H), 7.23 (d, J=2.4 Hz, 1 H), 6.68 (dd, J=5.7, 2.4 Hz, 1 H), 4.04 (m, 1 H), 3.84 (s, 3 H), 3.84-3.75 (m, 2 H), 3.70-3.59 (m, 2 H), 3.46-3.39 (m, 2 H), 1.60-1.47 (m, 4 H), 1.18 (d, J=15.1 Hz, 6 H); MS (ESI) m/z: 492.2 (M+H+).
Workup
- concentrationconcentrated to dryness
- custompurified via silica gel chromatography (MeOH/DCM)
Sources & evidence
- ORD record
- ord-48d89052cd62451eb8119b2a5c8b84f6
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09133183B2
Reaction notes
Loading…